Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.74 +0.01 (+0.14%)
As of: Aug 21, 2026 · 2:31 PM EDT

Drugs Made In America Acquisition (DMAA) Non-Current Assets (2024 - 2025)

Drugs Made In America Acquisition's (DMAA) quarterly Non-Current Assets came in at $239.9 million in Q4 2025, up 43852.39% YoY from N/an in Q4 2024, and up 0.97% on a QoQ basis from $237.6 million in Q3 2025.

Drugs Made In America Acquisition (DMAA) Non-Current Assets (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMAA) has 2 years of Non-Current Assets data on file, last reported at $239.9 million in Q4 2025.

  • Quarterly Non-Current Assets rose 43852.39% year-over-year to $239.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $239.9 million (up 43852.39% YoY) and the FY2025 annual result came in at $239.9 million, up 43852.39% from the prior year.
  • Non-Current Assets grew to $239.9 million in Q4 2025, from $237.6 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $239.9 million in Q4 2025 to a low of $545833.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 260.52 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 245.51 Mn
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 513.88 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 464.79 Mn
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 98.24 Mn
6 Aldel Financial 397.49 Mn 397.49 Mn - 247.40 Mn
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 313.51 Mn
8 Gores Holdings X 385.06 Mn 384.87 Mn - 374.14 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 376.71 Mn
10 Drugs Made In America Acquisition 215.82 Mn 215.82 Mn - 146.83 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 239.91 Mn
Sep 30, 2025 237.60 Mn
Jun 30, 2025 235.16 Mn
Mar 31, 2025 232.74 Mn
Dec 31, 2024 545,833.00